Panagora Asset Management’s Twist Bioscience TWST Stock Holding History

Panagora Asset Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,310	Closed	-$213K	–	1592
2022 Q1	$213K	Hold	4,310	–	–	﹤0.01%	1444
2021 Q4	$334K	Hold	4,310	–	–	﹤0.01%	1350
2021 Q3	$461K	Hold	4,310	–	–	﹤0.01%	1343
2021 Q2	$574K	Sell	4,310 -30	-0.7%	-$3.49K	﹤0.01%	1273
2021 Q1	$538K	Buy	4,340 +2,869	+195%	+$436K	﹤0.01%	1296
2020 Q4	$208K	Buy	+1,471	New	+$163K	﹤0.01%	1559

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Panagora Asset Management's TWST Position: Q2 2022 in Review

Panagora Asset Management sold out of Twist Bioscience (TWST) in Q2 2022, closing a stake of 4,310 shares — an estimated $213K sold.

Panagora Asset Management first reported a position in TWST in Q4 2020 and held it in 6 quarters. The position peaked at $574K in Q2 2021. 204 funds tracked by Wall St. Rank hold TWST as of Q2 2022.

Panagora Asset Management reported no remaining Twist Bioscience position as of Q2 2022 after selling out during the quarter.
Panagora Asset Management sold 4,310 Twist Bioscience shares in Q2 2022, an estimated $213K.
Panagora Asset Management first reported a position in Twist Bioscience in Q4 2020 and held it in 6 quarters.
Panagora Asset Management's Twist Bioscience position peaked at $574K in Q2 2021.
204 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2022.

Based on Panagora Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.